Fredrik Widman Sells 2,067 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 2,067 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the completion of the sale, the vice president directly owned 473 shares in the company, valued at approximately $260,150. The trade was a 81.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Intuitive Surgical Trading Up 2.2%

Shares of NASDAQ ISRG opened at $560.00 on Friday. The business has a 50-day moving average of $471.89 and a 200-day moving average of $500.87. The firm has a market capitalization of $200.75 billion, a price-to-earnings ratio of 74.07, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.84 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently issued reports on ISRG shares. BTIG Research upped their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Evercore ISI upped their price objective on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. HSBC increased their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Institutional Trading of Intuitive Surgical

Institutional investors have recently made changes to their positions in the stock. Norway Savings Bank raised its stake in Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares during the last quarter. IronOak Wealth LLC. purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth $1,099,000. Trust Co. of Oklahoma purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth $363,000. Amalgamated Bank grew its holdings in shares of Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares during the period. Finally, Neville Rodie & Shaw Inc. increased its position in Intuitive Surgical by 11.9% during the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.